ArticleDiabetes2007

Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages.

Bardia Askari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.